Search research articles
Contact Us
Filters
Showing results (1041-1050 of 1,467) with videos related to
Page
of 147
Sort By:
Annals of the Rheumatic Diseases
|
January 13, 2021
Role of joint damage, malalignment and inflammation in articular tenderness in rheumatoid arthritis, psoriatic arthritis and osteoarthritis
Irina Gessl, Mihaela Popescu, Victoria Schimpl, et al.
Seminars in Arthritis and Rheumatism
|
December 8, 2022
Comparison of disease activity index for psoriatic arthritis (DAPSA) and minimal disease activity (MDA) targets for patients with psoriatic arthritis: A post hoc analysis of data from phase 3 tofacitinib studies
Emilce E Schneeberger, Gustavo Citera, Peter Nash, et al.
Annals of the Rheumatic Diseases
|
August 2, 2011
A systematic literature review of drug therapies for the treatment of psoriatic arthritis: current evidence and meta-analysis informing the EULAR recommendations for the management of psoriatic arthritis
Zoe Ash, Cécile Gaujoux-Viala, Laure Gossec, et al.
Journal of Clinical Pharmacology
|
October 17, 2024
Pharmacokinetics and Safety of Intravenous Candidate Biosimilar CT-P47 and Reference Tocilizumab: A Randomized, Double-Blind, Phase 1 Study
Miwa Haranaka, Takashi Eto, Takanori Tanaka, et al.
Bone
|
November 21, 1998
High turnover bone disease following lung transplantation
M Aringer, H P Kiener, M D Koeller, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
August 20, 2014
Single-cell analysis of innate cytokine responses to pattern recognition receptor stimulation in children across four continents
Kinga K Smolen, Bing Cai, Edgardo S Fortuno, et al.
Clinical Therapeutics
|
October 9, 2022
Assessing the Cost-effectiveness of a Hypothetical Disease-modifying Therapy With Limited Duration for the Treatment of Early Symptomatic Alzheimer Disease
Malaz Boustani, Erin G Doty, Louis P Garrison, et al.
Annals of the Rheumatic Diseases
|
August 16, 2022
Low-dose interleukin-2 therapy in active systemic lupus erythematosus (LUPIL-2): a multicentre, double-blind, randomised and placebo-controlled phase II trial
Jens Y Humrich, Patrice Cacoub, Michelle Rosenzwajg, et al.
The Journal of Allergy and Clinical Immunology
|
October 1, 2025
Asthma remission in the context of other immune-mediated diseases
Josef Smolen, Bruce E Sands, Daniel J Jackson, et al.
Medrxiv : the Preprint Server for Health Sciences
|
August 8, 2025
An integrated framework for functional dissection of variable expressivity in genetic disorders
Jiawan Sun, Serena Noss, Deepro Banerjee, et al.
Page
of 147
Search research articles
Search
Showing results (1041-1050 of 1,467) with videos related to
Sort By:
Page
of 147
Annals of the Rheumatic Diseases
|
January 13, 2021
Role of joint damage, malalignment and inflammation in articular tenderness in rheumatoid arthritis, psoriatic arthritis and osteoarthritis
Irina Gessl, Mihaela Popescu, Victoria Schimpl, et al.
Seminars in Arthritis and Rheumatism
|
December 8, 2022
Comparison of disease activity index for psoriatic arthritis (DAPSA) and minimal disease activity (MDA) targets for patients with psoriatic arthritis: A post hoc analysis of data from phase 3 tofacitinib studies
Emilce E Schneeberger, Gustavo Citera, Peter Nash, et al.
Annals of the Rheumatic Diseases
|
August 2, 2011
A systematic literature review of drug therapies for the treatment of psoriatic arthritis: current evidence and meta-analysis informing the EULAR recommendations for the management of psoriatic arthritis
Zoe Ash, Cécile Gaujoux-Viala, Laure Gossec, et al.
Journal of Clinical Pharmacology
|
October 17, 2024
Pharmacokinetics and Safety of Intravenous Candidate Biosimilar CT-P47 and Reference Tocilizumab: A Randomized, Double-Blind, Phase 1 Study
Miwa Haranaka, Takashi Eto, Takanori Tanaka, et al.
Bone
|
November 21, 1998
High turnover bone disease following lung transplantation
M Aringer, H P Kiener, M D Koeller, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
August 20, 2014
Single-cell analysis of innate cytokine responses to pattern recognition receptor stimulation in children across four continents
Kinga K Smolen, Bing Cai, Edgardo S Fortuno, et al.
Clinical Therapeutics
|
October 9, 2022
Assessing the Cost-effectiveness of a Hypothetical Disease-modifying Therapy With Limited Duration for the Treatment of Early Symptomatic Alzheimer Disease
Malaz Boustani, Erin G Doty, Louis P Garrison, et al.
Annals of the Rheumatic Diseases
|
August 16, 2022
Low-dose interleukin-2 therapy in active systemic lupus erythematosus (LUPIL-2): a multicentre, double-blind, randomised and placebo-controlled phase II trial
Jens Y Humrich, Patrice Cacoub, Michelle Rosenzwajg, et al.
The Journal of Allergy and Clinical Immunology
|
October 1, 2025
Asthma remission in the context of other immune-mediated diseases
Josef Smolen, Bruce E Sands, Daniel J Jackson, et al.
Medrxiv : the Preprint Server for Health Sciences
|
August 8, 2025
An integrated framework for functional dissection of variable expressivity in genetic disorders
Jiawan Sun, Serena Noss, Deepro Banerjee, et al.
Page
of 147